Mucormycosis in COVID-19 patients with uncontrolled diabetes – the lethal triangle

1. Voigt K, Kirk PM. Classification of Zygomycetes: Reappraisal as coherent class based on a comparison between traditional versus molecular systematics. In: Batt CA, Tortorello ML (editors). Encyclopedia of Food Microbiology. Volume 2, Second Edition. Academic Press; 2014, p.54-67. Search in Google Scholar

2. Volk TJ. Fungi. In: Levin SA (editor). Encyclopedia of Biodiversity, Volume 3. Academic Press; 2001, p.141-63. Search in Google Scholar

3. Hussain S, Riad A, Singh A, Klugarová J, Antony B, Banna H, et al. Global prevalence of COVID-19-associated mucormycosis (CAM): Living systematic review and meta-analysis. J Fungi (Basel). 2021;7(11):985. DOI: 10.3390/jof7110985. Open DOISearch in Google Scholar

4. Ramaswami A, Sahu AK, Kumar A, Suresh S, Nair A, Gupta D, et al. COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients. QJM. 2021;114(7):464-70. DOI:10.1093/qjmed/hcab190. Open DOISearch in Google Scholar

5. Mishra Y, Prashar M, Sharma D, Akash, Kumar VP, Tilak TVSVGK. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr. 2021;15(4):102196. DOI: 10.1016/j.dsx.2021.102196. Open DOISearch in Google Scholar

6. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-53. DOI: 10.1086/432579. Open DOISearch in Google Scholar

7. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26-34. DOI: 10.1016/j.cmi.2018.07.011. Open DOISearch in Google Scholar

8. White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, et al. A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the Intensive Care Unit. Clin Infect Dis. 20201;73(7):e1634-44. DOI: 10.1093/cid/ciaa1298. Open DOISearch in Google Scholar

9. Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med. 2021;9(8):e77. DOI: 10.1016/S2213-2600(21)00265-4. Open DOISearch in Google Scholar

10. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-21. DOI: 10.1016/S1473-3099(19)30312-3. Open DOISearch in Google Scholar

11. Reid G, Lynch JP III, Fishbein MC, Clark NM. Mucormycosis. Semin Respir Crit Care Med. 2020;41(01):099-114. DOI: 10.1055/s-0039-3401992. Open DOISearch in Google Scholar

12. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S16-S22. DOI: 10.1093/cid/cir865. Open DOISearch in Google Scholar

13. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. DOI: 10.1016/S0140-6736(20)30211-7. Open DOISearch in Google Scholar

14. Bayram N, Ozsaygılı C, Sav H, Tekin Y, Gundogan M, Pangal E, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021;65(4):515-25. DOI:10.1007/s10384-021-00845-5. Open DOISearch in Google Scholar

15. Dubey S, Mukherjee D, Sarkar P, Mukhopadhyay P, Barman D, Bandopadhyay M, et al. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr. 2021;15(5):102267. DOI: 10.1016/j.dsx.2021.102267. Open DOISearch in Google Scholar

16. Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, et al. COVID-19-associated mucormycosis: An updated systematic review of literature. Mycoses. 2021;64(12):1452-9. DOI: 10.1111/myc.13338. Open DOISearch in Google Scholar

17. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. DOI: 10.1016/j.dsx.2021.05.019. Open DOISearch in Google Scholar

18. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693-704. DOI: 10.1056/NEJMoa2021436. Open DOISearch in Google Scholar

19. Garg R, Bharangar S, Gupta S, Bhardwaj S. Post Covid-19 infection presenting as rhino-orbital mycosis. Indian J Otolaryngol Head Neck Surg. 2021;1-8. DOI: 10.1007/s12070-021-02722-6. [Epub ahead of print]. Open DOISearch in Google Scholar

20. Dilek A, Ozaras R, Ozkaya S, Sunbul M, Sen EI, Leblebicioglu H. COVID-19-associated mucormycosis: Case report and systematic review. Travel Med Infect Dis. 2021;44:102148. DOI: 10.1016/j.tmaid.2021.102148. Open DOISearch in Google Scholar

21. Pippal SK, Kumar D, Ukawat L. Management challenge of rhino-orbito-cerebral mucormycosis in Covid 19 era: A prospective observational study. Indian J Otolaryngol Head Neck Surg. 2021;1-7. DOI: 10.1007/s12070-021-02947-5. [Epub ahead of print]. Open DOISearch in Google Scholar

22. Mitra S, Janweja M, Sengupta A. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control. Eur Arch Otorhinolaryngol. 2021;279(5):2417-22. DOI: 10.1007/s00405-021-07010-1. Open DOISearch in Google Scholar

23. Desai SM, Gujarathi-Saraf A, Agarwal EA. Imaging findings using a combined MRI/ CT protocol to identify the “entire iceberg” in post-COVID-19 mucormycosis presenting clinically as only “the tip”. Clin Radiol. 2021;76(10):784.e27-784.e33. DOI: 10.1016/j.crad.2021.07.002. Open DOISearch in Google Scholar

24. Gupta S, Ahuja P. Risk factors for procurence of mucormycosis and its manifestations post Covid-19: a single arm retrospective unicentric clinical study. Indian J Otolaryngol Head Neck Surg. 2021;1-8. DOI: 10.1007/s12070-021-02825-0. [Epub ahead of print]. Open DOISearch in Google Scholar

25. Panwar P, Gupta A, Kumar A, Gupta B, Navriya SC. Mucormycosis in COVID diabetic patients: a horrifying triad! Indian J Crit Care Med. 2021;25(11):1314-7. DOI: 10.5005/jp-journals-10071-24025. Open DOISearch in Google Scholar

26. Hernández JL, Buckley CJ. Mucormycosis. In: StatPearls [Internet]. [Updated 2021 Jul 25]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544364/. Search in Google Scholar

27. Ferry AP, Abedi S. Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases. Ophthalmology. 1983;90(9):1096-104. DOI: 10.1016/s0161-6420(83)80052-9. Open DOISearch in Google Scholar

28. Patel DD, Adke S, Badhe PV, Lamture S, Marfatia H, Mhatre P. COVID-19 associated rhino-orbito-cerebral mucormycosis: imaging spectrum and clinico-radiological correlation- a single centre experience. Clin Imaging. 2022;82:172-8. DOI:10.1016/j. clinimag.2021.10.014. Open DOISearch in Google Scholar

29. Vaughan C, Bartolo A, Vallabh N, Leong SC. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years? Clin Otolaryngol. 2018;43(6):1454-64. DOI:10.1111/coa.13175. Open DOISearch in Google Scholar

30. Dave TV, Nair AG, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical presentations, management and outcomes of rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19: A multi-centric study. Ophthalmic Plast Reconstr Surg. 2021;37(5):488-95. DOI: 10.1097/IOP.0000000000002030. Open DOISearch in Google Scholar

31. Honavar SG. Code Mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol. 2021;69(6):1361-5. DOI: 10.4103/ijo.IJO_1165_21. Open DOISearch in Google Scholar

32. Soni K, Das A, Sharma V, Goyal A, Choudhury B, Chugh A, et al. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience. J Mycol Med. 2021;32(2):101238. DOI: 10.1016/j.mycmed.2021.101238. Open DOISearch in Google Scholar

33. Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses. 2007;50(4):290-6. DOI: 10.1111/j.1439-0507.2007.01364.x. Open DOISearch in Google Scholar

34. Sugar AM. Mucormycosis. Clin Infect Dis. 1992;14 Suppl 1:S126-9. DOI: 10.1093/clinids/14.supplement_1.s126. Open DOISearch in Google Scholar

35. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am. 2000;33(2):349-65. DOI: 10.1016/s0030-6665(00)80010-9. Open DOISearch in Google Scholar

36. Jiang RS, Hsu CY. Endoscopic sinus surgery for rhinocerebral mucormycosis. Am J Rhinol. 1999;13(2):105-9. DOI: 10.2500/105065899782106751. Open DOISearch in Google Scholar

37. Avet PP, Kline LB, Sillers MJ. Endoscopic sinus surgery in the management of mucormycosis. J Neuroophthalmol. 1999;19(1):56-61. Search in Google Scholar

38. Songu M, Unlu HH, Gunhan K, Ilker SS, Nese N. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome. Am J Rhinol. 2008;22(1):98-103. DOI: 10.2500/ajr.2008.22.3121. Open DOISearch in Google Scholar

39. Luna JD, Ponssa XS, Rodríguez SD, Luna NC, Juárez CP. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis. Ophthalmic Surg Lasers. 1996;27(8):706-8. Search in Google Scholar

40. Sekaran A, Patil N, Sabhapandit S, Sistla SK, Reddy DN. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic. IJID Regions. 2022;2:99-106. DOI: 10.1016/j. ijregi.2021.12.009. Open DOISearch in Google Scholar